User Experience of a Centralized Hyperacute Stroke Service: A Prospective Evaluation

Background and Purpose— Centralizing hyperacute stroke unit (HASU) care services allows improved access to thrombolysis but could be associated with worse patient experience, particularly when early repatriation to a local stroke recovery unit occurs as this may result in discontinuity of care. A centralized model of care was introduced in London, United Kingdom, with 8 HASUs providing acute care for the whole 8.3 million population, with repatriation on day 3 to a local stroke recovery unit. The patient and carer experience of this model of care has not been previously reported. Methods— We undertook a prospective observational study of the new model of care in the South West London sector. Patient and carer experiences were evaluated using a modified Picker Questionnaire. Separate questionnaires were used for patients discharged directly home from the HASU, those repatriated to local stroke recovery units, and for carers of patients admitted to the HASU. Results— Despite moving from a selected to nonselected admission pattern, thrombolysis rates increased from 6% to 9%. High satisfaction rates were reported among both patients and carers. Patients discharged directly home had higher satisfaction levels than those requiring repatriation to their local stroke unit, who were older and had more severe stroke. A total of 47% of carers expressed anxiety over the repatriation from the HASU back to the local stroke recovery unit, but few patients and carers reported an impact of this move on patient recovery. Conclusion— Centralized HASU care is associated with good levels of patient and carer satisfaction.

[1]  C. McKevitt,et al.  Innovations in major system reconfiguration in England: a study of the effectiveness, acceptability and processes of implementation of two models of stroke care , 2013, Implementation Science.

[2]  K. H. Åsberg,et al.  Patient Dissatisfaction With Acute Stroke Care , 2009, Stroke.

[3]  Geoff Cohen,et al.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial , 2012, The Lancet.

[4]  C. McKevitt,et al.  Comparison of patients’ assessments of the quality of stroke care with audit findings , 2007, Quality & Safety in Health Care.

[5]  Sung-joon Min,et al.  The care transitions intervention: results of a randomized controlled trial. , 2006, Archives of internal medicine.

[6]  C. Wolfe,et al.  Stroke thrombolysis in England: an age stratified analysis of practice and outcome. , 2013, Age and ageing.

[7]  A. A. Parsons,et al.  Treatments for stroke , 2003, Expert opinion on emerging drugs.

[8]  P. Heuschmann,et al.  Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany , 2006, The Lancet Neurology.

[9]  Nicholas Steel,et al.  Pay-for-Performance in the United Kingdom: Impact of the Quality and Outcomes Framework—A Systematic Review , 2012, The Annals of Family Medicine.

[10]  B. Norrving,et al.  Thrombolytic Therapy Rates and Stroke Severity: An Analysis of Data From the Swedish Stroke Register (Riks-Stroke) 2007–2010 , 2012, Stroke.

[11]  Peter Langhorne,et al.  Organised inpatient (stroke unit) care for stroke. , 2007, The Cochrane database of systematic reviews.

[12]  Joanne Gray,et al.  Systematic review of stroke thrombolysis service configuration , 2009, Expert review of neurotherapeutics.

[13]  Gary A. Ford,et al.  Diagnostic Accuracy of Stroke Referrals From Primary Care, Emergency Room Physicians, and Ambulance Staff Using the Face Arm Speech Test , 2003, Stroke.

[14]  H. Cloft,et al.  Utilization of Intravenous Thrombolysis is Increasing in the United States , 2013, International journal of stroke : official journal of the International Stroke Society.

[15]  Gregory W Albers,et al.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.

[16]  P. Touboul,et al.  A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects , 2007, The Lancet Neurology.

[17]  H. Markus,et al.  Delivering regional thrombolysis via a hub-and-spoke model , 2010, Journal of the Royal Society of Medicine.

[18]  E. Armstrong,et al.  Analysis of a Coordinated Stroke Center and Regional Stroke Network on Access to Acute Therapy and Clinical Outcomes , 2013, Stroke.

[19]  Helen Hoenig,et al.  Postacute stroke guideline compliance is associated with greater patient satisfaction. , 2002, Archives of physical medicine and rehabilitation.

[20]  A. Rudd,et al.  Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  P. Barach,et al.  Improving Patient Handovers From Hospital to Primary Care , 2012, Annals of Internal Medicine.

[22]  B. Gabbe,et al.  Patient perspectives of care in a regionalised trauma system: lessons from the Victorian State Trauma System , 2013, The Medical journal of Australia.

[23]  Geoff Cohen,et al.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis , 2012, The Lancet.

[24]  S. Johnsen,et al.  Higher Stroke Unit Volume Associated With Improved Quality of Early Stroke Care and Reduced Length of Stay , 2012, Stroke.

[25]  S. Gutnikov,et al.  Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison , 2007, The Lancet.

[26]  R. Tresserras,et al.  Noncompliance With Certain Quality Indicators Is Associated With Risk-Adjusted Mortality After Stroke , 2012, Stroke.